top of page

Collaborative pathways for evidence-based nutrition care

At The Nutrition Compass I partner with healthcare teams to deliver nutrition and behaviour-change support aligned with clinical care. My role is to complement medical, surgical and allied-health management by translating the evidence into practical, patient-centred plans that fit real lives.

Medical and surgical interventions are often essential for managing metabolic, endocrine and obesity-related conditions, but they rarely achieve lasting weight-loss, nutritional, or behavioural change alone. I support your patients by:

  • Applying NHS, NICE and other national guidance on evidence-based nutrition, behavioural and lifestyle strategies, integrating the latest clinical research.

  • Preserving lean tissue, bone health, nutrient adequacy,  and metabolic stability during weight-loss or post-surgery recovery.

  • Bridging the transition from active treatment to long-term lifestyle maintenance.

  • Providing concise updates and summary reports and updates to referring clinicians (with patient consent) to ensure coordinated, patient-centred care.

​​

Evidence-based programmes for clinician collaboration

Below are three main programmes tailored for clinician referrals. Each pathway is designed to integrate with medical and surgical care, following NICE, NHS and other national guidance as well as latest clinical research. All programmes combine clinical nutrition, behavioural science, and patient-centred coaching to support safe, sustainable outcomes.

​​​​​

1. Weight Management & Metabolic Health Programme

 

Context: As outlined in NICE Guideline NG246 (2025), obesity should be managed as a long-term relapsing condition requiring ongoing, multidisciplinary support. NICE recommends that adults are offered interventions combining nutrition, physical activity, and behavioural strategies, rather than short-term dieting approaches.


Focus: This programme stabilises nutrition and eating patterns before introducing moderate, sustainable weight reduction while preserving lean mass and bone health. Behaviour-change strategies are used to build self-efficacy and resilience against relapse.


Why this matters clinically:

  • NG246 emphasises long-term, chronic-disease management framework for obesity, discouraging restrictive or short-term diets and supporting coordinated multidisciplinary care.

  • Sustained weight maintenance depends on protecting lean mass and metabolic rate, managing appetite regulation, and addressing behavioural and psychological adaptation during and after weight loss.

  • Systematic reviews highlight self-monitoring, intrinsic motivation, and social or clinical accountability as key predictors of long-term success.

  • Integrated behavioural and nutritional care improves metabolic stability and reduces relapse risk.

​​

Referral examples

  • Individuals experiencing weight regain after previous weight-loss attempts.

  • Adults with insulin resistance, NAFLD, metabolic syndrome, or elevated cardiovascular risk who need structured nutrition and behavioural support.

  • Patients awaiting bariatric assessment who require pre-surgical weight stabilisation.

​​

​​​

2. GLP-1 / Pharmacotherapy Adjunct Support Programme

​

Context: NICE TA875 (Semaglutide, 2023) and TA1026 (Tirzepatide, 2024) recommend these medicines only alongside a reduced-calorie diet, increased physical activity, and specialist multidisciplinary support. Pharmacotherapy is one element of a long-term weight-loss plan, not a stand-alone treatment.


Focus: Optimise nutrition during pharmacotherapy (active dose, consolidation, maintenance phases); protect muscle, bone and nutrient status; build sustainable eating and movement behaviours to support long-term outcomes.


Why this matters clinically:

  • NICE TA875 and TA1026 specify that GLP-1 and dual-agonist therapies must be used alongside nutrition, activity and behavioural support, not in isolation.

  • Structured tapering and continued nutrition and behaviour support after discontinuation can help maintain progress (Biomolecules, 2025).

  • Follow-up data show that combining exercise with GLP-1 treatment reduces later weight regain and preserves lean mass (eClinicalMedicine, 2024).

  • This programme supports continuity of care for patients transitioning off pharmacotherapy, aligning with NICE recommendations for relapse prevention and long-term weight maintenance.

​​

Referral examples

  • Adults prescribed semaglutide or tirzepatide.

  • Patients preparing to taper or stop medication, where relapse prevention is essential.

  • Individuals with NAFLD, pre-diabetes, or cardiovascular risk seeking integrated metabolic support.

3. Post-Bariatric Nutrition & Recovery Programme

​

Context: The management of adults following bariatric surgery requires long-term multidisciplinary care, including nutrition, supplementation, behavioural and psychological support. Current NICE guidance, NICE NG246: Medicines and Surgery (2025), along with recent research, emphasise continuity of care beyond surgery to prevent relapse and complications.
 


Focus: Ensure micronutrient sufficiency, preserve lean mass and bone health, and establish sustainable eating and activity patterns aligned with surgical anatomy. The programme rebuilds strength, mobility and self-efficacy while supporting long-term behavioural stability.


Why this matters clinically:

  • Inadequate follow-up is linked to muscle and bone loss, micronutrient deficiencies, and weight regain.

  • Early nutrition and behavioural support reduces the risk of psychological distress and maladaptive eating (e.g. grazing, binge behaviour).

  • Long-term success depends on integrating medical, surgical and lifestyle care, consistent with NICE’s chronic-disease framework for obesity.

  • Systematic reviews highlight that structured nutrition and exercise interventions post-surgery mitigate weight regain and preserve metabolic health (Curr Diab Rep, 2023; J Metab Bariatr Surg, 2023)

​​

Referral examples:

  • Patients following sleeve, bypass, or revision surgery with challenges around appetite, nutrient intake, or behaviour change.

  • Individuals experiencing early weight regain or nutritional complications post-surgery.

  • Patients preparing for revision or needing re-stabilisation support after discharge from surgical care.

Additional Services

​

Beyond these clinical pathways, tailored nutrition consultations and shorter-term programmes are available to support specific client needs. Examples include transitioning off GLP-1 therapy, supporting the menopause transition and bone health, or optimising energy and long-term metabolic health . Each service applies the same evidence-based, multidisciplinary framework, consistency with NICE and other national guidelines, and informed by the latest nutrient science research .

bottom of page